JAMA Internal Medicine Archives
Effective medications for opioid use disorder rarely used
Aug. 7, 2023—Vanderbilt research shows that most individuals diagnosed with opioid use disorder are not on recommended medications and even fewer remain in care.
More U.S. prostate cancer patients choosing active surveillance
Apr. 3, 2023—A Vanderbilt study found the number of prostate cancer patients in the U.S. choosing active surveillance over surgery or radiation has rapidly increased since 2010, rising from 16% to 60% for low-risk patients and from 8% to 22% for patients with favorable intermediate-risk cancers.
Study evaluates polygenic risk score for prostate cancer risk prediction
Mar. 16, 2023—A Vanderbilt study found that prostate cancer polygenic risk score has limited utility for enhancing prostate cancer screening.
VUMC’s ‘Shed-MEDS’ protocol can reduce risk of drug interactions in older people
Feb. 6, 2023—Vanderbilt University Medical Center's ‘Shed-MEDS’ protocol may reduce risk drug-drug interactions in older peole.
Smokers have better quit rates with hospital-based interventions than quitline help, but study indicates need for longer follow-up
Jun. 28, 2022—A health care system model that offered tobacco cessation treatment to smokers being discharged from a hospital produced a higher rate of tobacco abstinence during the three-month program than referral to a state-based telephone quitline, but the advantage disappeared at six months when both treatments produced comparable quit rates, researchers have found.
Gene variants increase risk of kidney failure in veterans of African ancestry with COVID-19: study
Feb. 10, 2022—Gene variants increased the risk of acute kidney injury and death in veterans of African ancestry who were hospitalized with COVID-19, possibly explaining some health disparities associated with COVID-19.
Two VUMC papers named among genomic medicine’s top 10
Dec. 16, 2021—Vanderbilt researchers wrote two of the “top 10” papers representing key advances in genomic medicine published between September 2020 and August 2021.
Allergic reaction to first dose of an mRNA COVID-19 vaccine should not keep people from getting the second dose: study
Jul. 26, 2021—An immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine — those manufactured by Moderna and Pfizer BioNTech — should not keep people from getting the second dose, a multi-hospital analysis shows.
Protein levels in urine after acute kidney injury predict future loss of kidney function
Jan. 28, 2020—High levels of protein in a patient’s urine after acute kidney injury is associated with increased risk of kidney disease progression, Vanderbilt researchers report.
Large-Scale Study Finds Higher Rates of Severe Psychological Distress and Impaired Physical Health among LGBT Populations
Jun. 27, 2016—In one of the largest, most representative health surveys conducted to date, lesbian, gay and bisexual adults reported substantially higher rates of severe psychological distress, heavy drinking and smoking, and impaired physical health than did heterosexuals.
VU study finds peanut consumption associated with decreased total mortality and mortality from cardiovascular diseases
Mar. 2, 2015—If you’re looking for a simple way to lower your risk of dying from a heart attack, consider going nuts.
Vanderbilt study finds use of methadone to treat pain carries increased risk of death
Jan. 20, 2015—Outside the hospital, use of methadone to treat pain carries a 46 percent increased risk of death when compared to the equally effective but more costly alternative, morphine SR (sustained release).
